Quantcast

Latest Multi-drug-resistant tuberculosis Stories

2010-09-02 06:00:00

SUNNYVALE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition. Funded and led by the Foundation for Innovative New Diagnostics...

2010-07-26 08:20:00

ROCKVILLE, Md., July 26 /PRNewswire/ -- Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced today the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug candidate for the treatment of TB, and TMC207, Tibotec lead TB drug candidate: Reddy, V.M., L. Einck, K. Andries, and C.A. Nacy. In Vitro Interactions between New...

2010-06-17 14:00:00

From West Baltimore to West Africa ZARIA, Nigeria, June 17 /PRNewswire-USNewswire/ -- This week, the U.S. Centers for Disease Control (CDC) Director, Dr. Tom Frieden, visited the Nigerian National TB and Leprosy Training Center (NTBLTC) to tour a multimillion dollar laboratory complex established by the Institute of Human Virology (IHV) of the University of Maryland School of Medicine in Baltimore, Maryland, and the Institute of Human Virology-Nigeria. This U.S.-Nigeria partnership was...

2010-05-19 11:33:03

Commentary: 'Tuberculosis anywhere is tuberculosis everywhere' Tuberculosis (TB) is an enormous global public health problem. Migration and failure by governments and the public health community to adequately treat and prevent TB among migrants is an important barrier to TB control. To reduce the incidence, spread and severity of tuberculosis, government policies must ensure that all patients have easy access to diagnosis and treatment, according to a commentary entitled "TB on the Move" in...

2010-04-06 14:00:00

HAYWARD, Calif. and SHANGHAI, April 6 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer (NYSE: PFE) to discover novel therapeutic agents to treat multi-drug resistant tuberculosis (MDR-TB). Cumencor Pharmaceuticals is a China-based biotechnology company applying MicuRx's...

2010-03-30 13:58:06

DALLAS -- Two new tuberculosis studies by UT Southwestern Medical Center researchers provide good news and bad news about the bacterium that infects nearly a third of the world's population and a disease that kills nearly 2 million people each year. The good news: A type of blood pressure medication shows promise at overcoming some drug-resistant tuberculosis, at least in the laboratory. The bad news: The Mycobacterium tuberculosis bacterium, which causes the disease, might be resistant to...

2010-03-24 09:00:00

WASHINGTON, March 24 /PRNewswire-FirstCall/ -- A Senate briefing today will discuss TB and drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively drug resistant (XDR-TB), the impact on global health and the current state of surveillance, diagnosis and treatment around the world. The briefing, Bringing Established Methods to Scale: New Perspectives in the Changing World of TB, is co-hosted by the Global Health Council, American Thoracic Society, Stop TB Partnership...

2010-03-24 07:00:00

WASHINGTON, March 24 /PRNewswire-USNewswire/ -- In a video message, USAID Administrator Rajiv Shah commemorated World Tuberculosis Day on March 24. Dr. Shah spoke about the global TB burden and highlighted important steps the United States is taking to stop TB around the world through a new five-year strategy. (Logo: http://www.newscom.com/cgi-bin/prnh/20091022/USAIDLOGO) Dr. Shah said: "Hi, my name is Raj Shah and I'm the Administrator for the U.S. Agency for International...

2010-03-23 11:59:00

WASHINGTON, March 23 /PRNewswire-USNewswire/ -- What: A Senate briefing, Bringing Established Methods to Scale: New Perspectives in the Changing World of TB, to discuss TB and drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively-drug resistant (XDR-TB), the impact on global health and the current state of surveillance, diagnosis and treatment around the world. Who: Co-hosts include the Global Health Council, American Thoracic Society, Stop TB Partnership and...

2010-03-18 08:00:00

WASHINGTON, March 18 /PRNewswire/ -- Ahead of World TB Day, US Food and Drug Administration Commissioner Margaret Hamburg helped public and private sector partners launch a new collaboration to significantly accelerate the development of combination treatments for tuberculosis -- and replace an almost 50-year-old drug regimen. Created by the Global Alliance for TB Drug Development, the Critical Path Institute, and the Bill & Melinda Gates Foundation, the initiative could potentially...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related